S 1818
Official Title: A bill to significantly lower prescription drug prices for patients in the United States by ending government-granted monopolies for manufacturers who charge drug prices that are higher than the median prices at which the drugs are available in other coun
Introduced: 05/20/2025
Passed House:
Passed Senate:
To President:
Became Law:
Summary:
Action(s):
- 05/20/2025 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- 05/20/2025 - Introduced in Senate
Bill Details
-
Prescription Drug Price Relief Act of 2025
-
Senate
-
Congress Number: 119
